Chronic Fatigue Syndrome Cases to Double Post-COVID

Up to 80,000 people in Austria are estimated to suffer from chronic fatigue syndrome, also known as ME/CFS or myalgic encephalomyelitis/chronic fatigue syndrome. The number of ME/CFS patients is expected to rise drastically due to long-term effects of the COVID-19 pandemic. However, research in the field has neither identified mechanisms of disease onset nor causal treatment approaches. Scientists at MedUni Vienna have now identified possible biomarkers that could improve the diagnosis and treatment of long-lasting and debilitating fatigue. The study has recently been published in the Journal of Clinical Medicine. The study by Eva Untersmayr-Elsenhuber and her team from MedUni

Chronic Fatigue Syndrome Cases to Double Post-COVID as seen on The Hippocratic Post.

Source: hippocraticpost.com